Integrated BioPharmaINBP 
$0.22-4.35%24h
-4.35%24h
Global rank33865
Market cap$6.59M
Change 7d15.79%
YTD Performance-12.00%
SP500 benchmarkUnderperform
P/E-193.83
P/S0.13
Revenue$50.67M
Earnings-$34.00K
Dividend yield-
Main Sector
Consumer Defensive
Category
Integrated BioPharma (INBP) Cash on Hand
INBP Cash on Hand in 2022: $1.32M
According to Integrated BioPharma latest financial reports the cash on hand of INBP is $1.32M, an increase of 297.58% to 2022. At the end of 2022 company had $331.00K cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
INBP Cash on Hand History from 2019 to 2023
-
Value:-
INBP Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $1.32M | 297.58% |
| 2022 | $331.00K | 57.62% |
| 2021 | $210.00K | -47.76% |
| 2020 | $402.00K | -15.37% |
| 2019 | $475.00K | - |
View the Top Cash on Hand Companies 
